233 related articles for article (PubMed ID: 33036498)
1. Effect of
Bonvicini F; Pagnotta E; Punzo A; Calabria D; Simoni P; Mirasoli M; Passerini N; Bertoni S; Ugolini L; Lazzeri L; Gentilomi GA; Caliceti C; Roda A
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036498
[TBL] [Abstract][Full Text] [Related]
2. Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models.
Chen YP; Lee TY; Hong WS; Hsieh HH; Chen MJ
J Dairy Sci; 2013; 96(12):7467-77. PubMed ID: 24140320
[TBL] [Abstract][Full Text] [Related]
3. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus plantarum L9 but not Lactobacillus acidophilus LA reduces tumour necrosis factor induced bacterial translocation in Caco-2 cells.
Wang B; Chen J; Wang S; Zhao X; Lu G; Tang X
Benef Microbes; 2017 May; 8(3):497-505. PubMed ID: 28441885
[TBL] [Abstract][Full Text] [Related]
5. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB.
Bielaszewska M; Marejková M; Bauwens A; Kunsmann-Prokscha L; Mellmann A; Karch H
Int J Med Microbiol; 2018 Oct; 308(7):882-889. PubMed ID: 29934223
[TBL] [Abstract][Full Text] [Related]
6. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
8. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
Howe KL; Reardon C; Wang A; Nazli A; McKay DM
Am J Pathol; 2005 Dec; 167(6):1587-97. PubMed ID: 16314472
[TBL] [Abstract][Full Text] [Related]
10. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8.
Berin MC; Darfeuille-Michaud A; Egan LJ; Miyamoto Y; Kagnoff MF
Cell Microbiol; 2002 Oct; 4(10):635-48. PubMed ID: 12366401
[TBL] [Abstract][Full Text] [Related]
11. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression.
Putaala H; Salusjärvi T; Nordström M; Saarinen M; Ouwehand AC; Bech Hansen E; Rautonen N
Res Microbiol; 2008; 159(9-10):692-8. PubMed ID: 18783733
[TBL] [Abstract][Full Text] [Related]
12. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
Yi H; Hu W; Chen S; Lu Z; Wang Y
J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
[TBL] [Abstract][Full Text] [Related]
13.
Xing TL; Bian X; Ma CM; Yang Y; Liu XF; Wang Y; Fan J; Zhang N
Food Funct; 2023 Mar; 14(5):2472-2480. PubMed ID: 36799431
[TBL] [Abstract][Full Text] [Related]
14. The Protective Effects of 2'-Fucosyllactose against
Wang Y; Zou Y; Wang J; Ma H; Zhang B; Wang S
Nutrients; 2020 May; 12(5):. PubMed ID: 32369957
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 protects against intestinal epithelial barrier dysfunction caused by hypoxia-reoxygenation.
Howe KL; Lorentz RJ; Assa A; Pinnell LJ; Johnson-Henry KC; Sherman PM
Shock; 2015 May; 43(5):483-9. PubMed ID: 25608140
[TBL] [Abstract][Full Text] [Related]
16. Blend of organic acids and medium chain fatty acids prevents the inflammatory response and intestinal barrier dysfunction in mice challenged with enterohemorrhagic Escherichia coli O157:H7.
Wang J; Lu J; Xie X; Xiong J; Huang N; Wei H; Jiang S; Peng J
Int Immunopharmacol; 2018 May; 58():64-71. PubMed ID: 29555328
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific.
Stöber H; Maier E; Schmidt H
Int J Food Microbiol; 2010 Nov; 144(1):133-40. PubMed ID: 20920833
[TBL] [Abstract][Full Text] [Related]
18. Fitness of Enterohemorrhagic Escherichia coli (EHEC)/Enteroaggregative E. coli O104:H4 in Comparison to That of EHEC O157: Survival Studies in Food and In Vitro.
Böhnlein C; Kabisch J; Meske D; Franz CM; Pichner R
Appl Environ Microbiol; 2016 Nov; 82(21):6326-6334. PubMed ID: 27542931
[TBL] [Abstract][Full Text] [Related]
19. A Fixed Combination of Probiotics and Herbal Extracts Attenuates Intestinal Barrier Dysfunction from Inflammatory Stress in an In vitro Model Using Caco-2 Cells.
Cocetta V; Catanzaro D; Borgonetti V; Ragazzi E; Giron MC; Governa P; Carnevali I; Biagi M; Montopoli M
Recent Pat Food Nutr Agric; 2019; 10(1):62-69. PubMed ID: 30088455
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the effect of ethanol extracts from
Zhang G; Yan X; Xia J; Zhao J; Ma M; Yu P; Gong D; Zeng Z
Food Funct; 2021 Oct; 12(19):9197-9210. PubMed ID: 34606534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
